NDC 70700-823 - Norethindrone Acetate and Ethinyl Estradiol
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 70700-823
- Manufacturer
- Xiromed, LLC | XIROMED PHARMA ESPANA, S.L. | Laboratorios Leon Farma, SAU
- Effective date
- 2023-07-12
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Norethindrone Acetate and Ethinyl Estradiol Tablets and Ferrous Fumarate Tablets | Xiromed, LLC | XIROMED PHARMA ESPANA, S.L. | Laboratorios Leon Farma, SAU | 2023-07-12 | HUMAN PRESCRIPTION DRUG LABEL |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Lopreeza | ESTRADIOL/NORETHINDRONE ACETATE | Amneal Pharmaceuticals NY LLC | bf0e39cb-95e7-4831-92d2-0b3f071aeaae | 2017-11-30 | Boxed warning, Warnings, Adverse reactions | 9S44LIC7OJ |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.